SBFM
Sunshine Biopharma Inc
$
1.400
- Overview
- Forecast
- Valuation
- Earnings
Line
|
Candle
1D
5D
1M
3M
6M
YTD
1Y
5Y
High
1.410
Open
1.388
VWAP
1.38
Vol
33.78K
Mkt Cap
6.38M
Low
1.360
Amount
46.48K
EV/EBITDA(TTM)
--
Total Shares
18.95M
EV
-1.73M
EV/OCF(TTM)
--
P/S(TTM)
0.06
Sunshine Biopharma Inc. is a pharmaceutical company engaged in offering and researching life-saving medicines in a variety of therapeutic areas, including oncology and antivirals. The Company has approximately 70 generic prescription drugs on the market in Canada. In addition, the Company is conducting a proprietary drug development program which is comprised of K1.1 mRNA, an mRNA-Lipid Nanoparticle targeted for liver cancer, and PLpro protease inhibitor, a small molecule for the treatment of SARS Coronavirus infections. The Company operates through two segments: Prescription Generic Pharmaceuticals (Generic Pharmaceuticals) and Nonprescription Over-The-Counter Products (OTC Products). The Company operates two wholly owned subsidiaries: Nora Pharma Inc., which has a portfolio of pharmaceutical products consisting of various prescription drugs on the market in Canada, and Sunshine Biopharma Canada Inc., which develops and sells nonprescription over-the-counter (OTC) products.
Show More
Market Estimates
Earnings Estimates
Revenue
YoY Chg
EPS
YoYChg
FY2025Q3
FY2025Q2
FY2025Q1
12.10M
+43.45%
--
--
11.20M
+20.39%
--
--
0.00
-100%
--
--
Estimates Revision
The market is revising No Change the revenue expectations for Sunshine Biopharma, Inc. (SBFM) for FY2025, with the revenue forecasts being adjusted by 0% over the past three months. During the same period, the stock price has changed by 12.00%.
Revenue Estimates for FY2025
No Change
0.00%
In Past 3 Month
Stock Price
Go Up
+12.00%
In Past 3 Month
1 Analyst Rating
400.00% Upside
Wall Street analysts forecast SBFM stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for SBFM is 7.00 USD with a low forecast of 7.00 USD and a high forecast of 7.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
1 Buy
0 Hold
0 Sell
Moderate Buy
400.00% Upside
Current: 1.400
Low
7.00
Averages
7.00
High
7.00
400.00% Upside
Current: 1.400
Low
7.00
Averages
7.00
High
7.00
Aegis Capital
David Bouchey
Strong Buy
Reiterates
$15
2024-12-05
Reason
Aegis Capital
David Bouchey
Price Target
$15
2024-12-05
Reiterates
Strong Buy
Reason
See All Ratings
Valuation Metrics
The current forward P/E ratio for Sunshine Biopharma Inc (SBFM.O) is -3.44, compared to its 5-year average forward P/E of -1.22. For a more detailed relative valuation and DCF analysis to assess Sunshine Biopharma Inc 's fair value, click here.
Forward PE
The forward P/E ratio is a valuation metric that divides a company's current stock price by its estimated future earnings per share over the next 12 months.
N/A
5Y Average PE
-1.22
Current PE
-3.44
Overvalued PE
0.90
Undervalued PE
-3.34
Forward EV/EBITDA
The forward EV/EBITDA ratio is a valuation metric that divides a company's enterprise value (EV) by its estimated future earnings before interest, taxes, depreciation, and amortization (EBITDA) over the next 12 months.
N/A
5Y Average EV/EBITDA
0.00
Current EV/EBITDA
0.00
Overvalued EV/EBITDA
0.00
Undervalued EV/EBITDA
0.00
Forward PS
The forward P/S ratio is a valuation metric that divides a company's current stock price by its estimated future sales (or revenue) per share over the next 12 months.
N/A
5Y Average PS
0.13
Current PS
0.13
Overvalued PS
0.37
Undervalued PS
-0.10
Financials
Annual
Quarterly
FY2025Q1
YoY :
+18.04%
8.90M
Total Revenue
FY2025Q1
YoY :
-4.06%
-1.30M
Operating Profit
FY2025Q1
YoY :
-8.10%
-1.18M
Net Income after Tax
FY2025Q1
YoY :
-98.90%
-0.44
EPS - Diluted
FY2025Q1
YoY :
-50.43%
-1.93M
Free Cash Flow
FY2025Q1
YoY :
-2.32%
29.95
Gross Profit Margin - %
FY2025Q1
YoY :
-18.89%
-34.64
FCF Margin - %
FY2025Q1
YoY :
-22.15%
-13.25
Net Margin - %
Trading Trends
Insider
Insiders are Neutral. There are no significant trading trends over the last month.
Sold
0-3
Months
0.0
USD
0
3-6
Months
0.0
USD
0
6-9
Months
0.0
USD
0
0-12
Months
0.0
USD
0
Bought
0-3
0
0.0
USD
Months
3-6
0
0.0
USD
Months
6-9
0
0.0
USD
Months
0-12
0
0.0
USD
Months
Hedge Fund
Hedge Funds areBuying! The buying amount has increased 11812.88% over the last quarter.
Sold
0-3
Months
0.0
Volume
0
3-6
Months
0.0
Volume
0
6-9
Months
0.0
Volume
0
0-12
Months
0.0
Volume
0
Bought
0-3
0
0.0
Volume
Months
3-6
0
0.0
Volume
Months
6-9
1
314.5K
Volume
Months
0-12
0
0.0
Volume
Months
Congress Trading
Congress are Neutral. There are no significant trading trends over the last month.
Sold
0-3
Months
0.0
USD
0
3-6
Months
0.0
USD
0
6-9
Months
0.0
USD
0
0-12
Months
0.0
USD
0
Bought
0-3
0
0.0
USD
Months
3-6
0
0.0
USD
Months
6-9
0
0.0
USD
Months
0-12
0
0.0
USD
Months
Insider
Insiders are Neutral. There are no significant trading trends over the last month.
Sold
0-3
Months
0.0
USD
0
3-6
Months
0.0
USD
0
6-9
Months
0.0
USD
0
0-12
Months
0.0
USD
0
Bought
0-3
0
0.0
USD
Months
3-6
0
0.0
USD
Months
6-9
0
0.0
USD
Months
0-12
0
0.0
USD
Months
SBFM News & Events
Events Timeline
2025-07-02 (ET)
2025-07-02
08:22:07
Sunshine Biopharma's Nora Pharma launches NIOPEG
2025-06-11 (ET)
2025-06-11
08:39:01
Sunshine Biopharma launches generic gabapentin for neuropathic pain
2025-05-06 (ET)
2025-05-06
08:45:12
Sunshine Biopharma launches generic Lurasidone for schizophrenia
Sign Up For More Events
Sign Up For More Events
News
2.0
04-03TipRanks3 Penny Stocks to Watch Now, 4/3/25
9.0
04-02BenzingaSunshine Biopharma Stock Shoots Higher On Encouraging Data From mRNA-Based Liver Cancer Drug
4.5
04-02BenzingaUS Stock Futures Slip Ahead Of 'Liberation Day' Tariffs Announcement: Expert Points To Uncertainty Amid Higher Risk Premia
Sign Up For More News
People Also Watch
VERB
Verb Technology Company Inc
16.800
USD
-14.98%
AMIX
Autonomix Medical Inc
1.200
USD
-3.23%
MBRX
Moleculin Biotech Inc
0.674
USD
-0.44%
TNON
Tenon Medical Inc
1.390
USD
+2.96%
LXEH
Lixiang Education Holding Co Ltd
1.760
USD
-27.87%
VSME
VS Media Holdings Ltd
1.315
USD
-0.38%
EJH
E-Home Household Service Holdings Ltd
1.490
USD
-1.32%
YGMZ
MingZhu Logistics Holdings Ltd
0.808
USD
-0.86%
ELAB
PMGC Holdings Inc
1.880
USD
-0.27%
FAQ
What is Sunshine Biopharma Inc (SBFM) stock price today?
The current price of SBFM is 1.4 USD — it has increased 0 % in the last trading day.
What is Sunshine Biopharma Inc (SBFM)'s business?
What is the price predicton of SBFM Stock?
What is Sunshine Biopharma Inc (SBFM)'s revenue for the last quarter?
What is Sunshine Biopharma Inc (SBFM)'s earnings per share (EPS) for the last quarter?
What changes have occurred in the market's expectations for Sunshine Biopharma Inc (SBFM)'s fundamentals?
How many employees does Sunshine Biopharma Inc (SBFM). have?